Literature DB >> 16756737

Ghrelin and peptide YY levels after a variant of biliopancreatic diversion with Roux-en-Y gastric bypass versus after colectomy: a prospective comparative study.

Christos Stratis1, Theodore Alexandrides, Kostas Vagenas, Fotis Kalfarentzos.   

Abstract

BACKGROUND: The gastrointestinal peptide hormones ghrelin and PYY have been shown to play a role in the regulation of metabolism and appetite. We investigate the effect of Biliopancreatic diversion with Roux-en-Y gastric bypass (BPD-RYGBP) on the circulating levels of ghrelin and peptide YY during the first 3 months postoperatively as compared to the effects of colectomy, an abdominal operation of similar severity.
METHODS: Fasting plasma levels of ghrelin and PYY were determined in 20 super-obese patients (BMI> or =50) who underwent BPD-RYGBP and in 13 patients who underwent colectomy for large bowel cancer. Fasting plasma ghrelin and PYY levels were measured preoperatively and during the postoperative period on days 1, 3, 7, 30 and 90 in all patients of both groups, and at 1 year for 10 of the patients who had attained 1-year follow up.
RESULTS: Preoperatively, both plasma ghrelin and PYY levels were lower in the BPD-RYGBP group of patients. A temporary decrease in plasma ghrelin levels was observed in both groups of patients during the immediate postoperative period, with a gradual return to preoperative levels by the 3rd month. In addition, ghrelin concentrations increased at 1 year to levels 40% higher than those at baseline, in 10 of the BPD-RYGBP patients who had completed the 1-year follow-up (P=0.004). Plasma PYY levels in the colectomy group decreased in the first 3 postoperative days and then returned to baseline. In contrast, PYY levels in the BPD-RYGBP group did not change during the early postoperative period but increased to levels 50% higher at 3 months (P<0.001) and 170% higher at 1 year (P<0.001) than the baseline.
CONCLUSIONS: The great postoperative increase in the levels of the anorexigenic peptide PYY following BPD-RYGBP may contribute to the reduced appetite observed after this type of bariatric surgery. The changes in ghrelin levels postoperatively make its contribution to the appetite suppression less likely.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16756737     DOI: 10.1381/096089206777346772

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  12 in total

1.  Effects of two variants of Roux-en-Y Gastric bypass on metabolism behaviour: focus on plasma ghrelin concentrations over a 2-year follow-up.

Authors:  Noelia Pérez-Romero; Assumpta Serra; Maria Luisa Granada; Miquel Rull; Antonio Alastrué; Maruja Navarro-Díaz; Ramón Romero; Jaime Fernández-Llamazares
Journal:  Obes Surg       Date:  2009-12-17       Impact factor: 4.129

2.  Do colorectal cancer resections improve diabetes in long-term survivors? A case-control study.

Authors:  Joel Faintuch; Silvia Y Hayashi; Sergio C Nahas; Osmar K Yagi; Salomao Faintuch; Ivan Cecconello
Journal:  Surg Endosc       Date:  2013-11-01       Impact factor: 4.584

3.  Long-term changes in leptin, chemerin and ghrelin levels following different bariatric surgery procedures: Roux-en-Y gastric bypass and sleeve gastrectomy.

Authors:  Ximena Terra; Teresa Auguet; Esther Guiu-Jurado; Alba Berlanga; Josep Maria Orellana-Gavaldà; Mercè Hernández; Fàtima Sabench; Jose Antonio Porras; Jordi Llutart; Salomé Martinez; Carmen Aguilar; Daniel Del Castillo; Cristóbal Richart
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

Review 4.  Metabolic surgery-principles and current concepts.

Authors:  M Gass; C Beglinger; R Peterli
Journal:  Langenbecks Arch Surg       Date:  2011-08-26       Impact factor: 3.445

Review 5.  Changes in ghrelin levels following bariatric surgery: review of the literature.

Authors:  Kevin Tymitz; Amy Engel; Sarah McDonough; Mary Pat Hendy; George Kerlakian
Journal:  Obes Surg       Date:  2011-01       Impact factor: 4.129

6.  Bariatric surgery and type 2 diabetes mellitus: surgically induced remission.

Authors:  Talar Tejirian; Candice Jensen; Erik Dutson
Journal:  J Diabetes Sci Technol       Date:  2008-07

Review 7.  Pathophysiology of obesity: why surgery remains the most effective treatment.

Authors:  Talat Waseem; Kris M Mogensen; David B Lautz; Malcolm K Robinson
Journal:  Obes Surg       Date:  2007-10       Impact factor: 4.129

8.  Different effect of laparoscopic Roux-en-Y gastric bypass and open biliopancreatic diversion of Scopinaro on serum PYY and ghrelin levels.

Authors:  E Garcia-Fuentes; L Garrido-Sanchez; J M Garcia-Almeida; J Garcia-Arnes; J L Gallego-Perales; J Rivas-Marin; S Morcillo; I Cardona; F Soriguer
Journal:  Obes Surg       Date:  2008-06-10       Impact factor: 4.129

9.  The gut hormone response following Roux-en-Y gastric bypass: cross-sectional and prospective study.

Authors:  Dimitrios J Pournaras; Alan Osborne; Simon C Hawkins; David Mahon; Mohammad A Ghatei; Steve R Bloom; Richard Welbourn; Carel W le Roux
Journal:  Obes Surg       Date:  2009-10-14       Impact factor: 4.129

10.  Effect of weight loss by diet or gastric bypass surgery on peptide YY3-36 levels.

Authors:  Blanca Oliván; Julio Teixeira; Mousumi Bose; Baani Bawa; Tangel Chang; Heather Summe; Hongchan Lee; Blandine Laferrère
Journal:  Ann Surg       Date:  2009-06       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.